Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways

The endocannabinoid system as a target for the treatment of neurodegenerative disease

(2010) Emma L Scotter et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoid-Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

(2010) Javier Fernández-Ruiz et al.   CNS Neuroscience & Therapeutics

The endocannabinoid system as a target for the treatment of neuronal damage

(2010) Javier Fernández-Ruiz et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation

(2010) Oscar Gomez et al.   GLIA

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

(2010) R. G. Pertwee et al.   PHARMACOLOGICAL REVIEWS

IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways

(2009) Olivia Bibollet-Bahena et al.   JOURNAL OF NEUROCHEMISTRY

Activation of the Mammalian Target of Rapamycin (mTOR) Is Essential for Oligodendrocyte Differentiation

(2009) W. A. Tyler et al.   JOURNAL OF NEUROSCIENCE

Akt Signals through the Mammalian Target of Rapamycin Pathway to Regulate CNS Myelination

(2009) S. P. Narayanan et al.   JOURNAL OF NEUROSCIENCE

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling

(2009) Emma Puighermanal et al.   NATURE NEUROSCIENCE

Constitutively Active Akt Induces Enhanced Myelination in the CNS

(2008) A. I. Flores et al.   JOURNAL OF NEUROSCIENCE

A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner

(2008) Maria Beatriz Goncalves et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

The endocannabinoid system is modulated in response to spinal cord injury in rats

(2008) Daniel Garcia-Ovejero et al.   NEUROBIOLOGY OF DISEASE

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease

(2008) G. Cabral et al.   Endocrine Metabolic & Immune Disorders-Drug Targets